AVCRFPharmaceutical PreparationsFiscal year ends December 31
Avricore Health Inc.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Jun 16, 2025
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
Avricore Health Inc. income statement
Ratios
Latest available, balances at Dec 31, 2024
Profitability, FY2024
- Gross margin
- 40.4%
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2024
- –
Financial strength
- Current ratio
- –
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
Valuation ratios need the share price and fill in once daily prices are connected.